Informatie: Dit is niet de actueelste versie van het datamodel. Een versieoverzicht vindt u links onder Versies. De actueelste versie vindt u hier.
Informatie:
Fout:
ID
22514
Beschrijving
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss; ODM derived from: https://clinicaltrials.gov/show/NCT00333229
Link
https://clinicaltrials.gov/show/NCT00333229
Trefwoorden
Versies (2)
- 06-06-17 06-06-17 -
- 06-06-17 06-06-17 -
Geüploaded op
6 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0 Legacy
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women NCT00333229
Eligibility Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women NCT00333229
- StudyEvent: Eligibility
Similar models
Eligibility Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women NCT00333229
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
female patients with histologically confirmed incident invasive breast cancer (t1-4) with no evidence of regional lymph node metastasis (n0) or distant metastasis (m0) and after complete primary tumor resection and axillary lymph node dissection less than 90 days before start of study drug treatment.
boolean
Hormone Receptor Negative
Item
hormone receptor status is negative
boolean
C0019929 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,2])
Premenopausal | Menstruation Spontaneous Regular | Estradiol level Premenopausal
Item
patient is premenopausal (spontaneous and regular menses with premenopausal estradiol levels (>10ng/dl)
boolean
C0232969 (UMLS CUI [1])
C0025344 (UMLS CUI [2,1])
C0205359 (UMLS CUI [2,2])
C0205272 (UMLS CUI [2,3])
C1443016 (UMLS CUI [3,1])
C0232969 (UMLS CUI [3,2])
C0025344 (UMLS CUI [2,1])
C0205359 (UMLS CUI [2,2])
C0205272 (UMLS CUI [2,3])
C1443016 (UMLS CUI [3,1])
C0232969 (UMLS CUI [3,2])
Chemotherapy, Adjuvant | Cytotoxic Chemotherapy | Chemotherapy cycle Adjuvant Quantity | Neoadjuvant Chemotherapy
Item
patient receives adjuvant standard chemotherapy with approved cytotoxic chemotherapeutic drugs (e.g. ac 4-6 cycles) (prior neoadjuvant ct is allowed)
boolean
C0085533 (UMLS CUI [1])
C0677881 (UMLS CUI [2])
C1302181 (UMLS CUI [3,1])
C1522673 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0600558 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
C0677881 (UMLS CUI [2])
C1302181 (UMLS CUI [3,1])
C1522673 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0600558 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
Bone Density T score
Item
bone density at study entry > -2.5 t-score
boolean
C0005938 (UMLS CUI [1,1])
C3854607 (UMLS CUI [1,2])
C3854607 (UMLS CUI [1,2])
Diphosphonates | Estrogens | Therapeutic procedure Osteoporosis | Calcium | Vitamin D
Item
prior treatment with bisphosphonates and estrogens or treatments for osteoporosis in addition to calcium and vitamin d
boolean
C0012544 (UMLS CUI [1])
C0014939 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0029456 (UMLS CUI [3,2])
C0006675 (UMLS CUI [4])
C0042866 (UMLS CUI [5])
C0014939 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0029456 (UMLS CUI [3,2])
C0006675 (UMLS CUI [4])
C0042866 (UMLS CUI [5])
ID.7
Item
severe physical or psychological concomitant diseases and other known concurrent, severe medical disorder jeopardizing the life of the patient in the immediate future (e.g., myocardial infarction in previous six months, angina pectoris despite treatment, uncontrolled severe arterial hypertension, progressive cardiac or respiratory failure)
boolean
Hypersensitivity Diphosphonates
Item
known hypersensitivity to bisphosphonates
boolean
C0020517 (UMLS CUI [1,1])
C0012544 (UMLS CUI [1,2])
C0012544 (UMLS CUI [1,2])
Abnormal renal function
Item
abnormal renal function
boolean
C0151746 (UMLS CUI [1])
ID.10
Item
current active dental problems including infection of the teeth or jawbone (maxilla or mandibular); dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw (onj), of exposed bone in the mouth, or of slow healing after dental procedures and recent (within 6 weeks) or planned dental or jaw surgery (e.g. extraction, implants)
boolean